Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Does Vaxart Still Have a Future?

TheMotleyFool

0 0

Vaxart (NASDAQ: VXRT) recently reported preliminary results from phase 1 study of its tablet COVID-19 vaccine candidate. Although there were some positive data in those results, many investors worried about the failure of the experimental vaccine to produce neutralizing antibodies in study participants. The biotech stock plunged after the clinical update. In this Motley Fool Live video recorded on Feb. 3, 2021, Fool.com contributors Keith Speights and Brian Orelli answer a viewer's question about whether Vaxart still has a future.

Source Fool.com

Like: 0

VXRT

Share